Acumen Pharmaceuticals (ABOS) Other Non-Current Assets (2021 - 2026)

Acumen Pharmaceuticals (ABOS) has 6 years of Other Non-Current Assets data on file, last reported at $231000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed 0.43% year-over-year to $231000.0; the trailing twelve-month figure through Mar 2026 stood at $231000.0 (changed 0.43% YoY), and the FY2025 full-year result was $350000.0, down 27.98% from the prior year.
• Other Non-Current Assets retreated to $231000.0 in Q1 2026, from $350000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $486000.0 in Q4 2024 to a low of $79000.0 in Q1 2022.
• A 5-year average of $234562.5 and a median of $231500.0 in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets jumped 978.57% in 2022 and sank 45.41% in 2025, its largest moves.
• Tracing ABOS's Other Non-Current Assets over 5 years: stood at $151000.0 in 2022, then surged by 54.3% to $233000.0 in 2023, then soared by 108.58% to $486000.0 in 2024, then retreated by 27.98% to $350000.0 in 2025, then plunged by 34.0% to $231000.0 in 2026.
• Business Quant data shows ABOS's Other Non-Current Assets at $231000.0 in Q1 2026, $350000.0 in Q4 2025, and $232000.0 in Q3 2025.